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a  b  s  t  r  a  c  t
BACTEC 460 has now been phased out, so the search for an alternative is imperative. We
have  determined the activity of standard anti-tuberculosis drugs against intramacrophage
Mycobacterium  tuberculosis, in vitro, by using BACTEC 460 and MGIT 960 methods. The min-
imum inhibitory concentrations of isoniazid, rifampicin, ethambutol and streptomycin
against  intracellular M. tuberculosis H37Rv were found to be 0.2, 0.8, 8.0, and 5.0 g/mL,
respectively,  by both methods. These results show a signiﬁcant (p < 0.001) concordance
between  minimum inhibitory concentrations obtained by these two different methods.
MGIT  960 system uses a robust ﬂorescence quenching-based oxygen sensor, requires no
radioisotope,  is safe, and relatively easy to operate. Apparently, this is the ﬁrst report wherein
MGIT  960 has been validated for anti-tubercular susceptibility testing against intracellularM.  tuberculosis H37Rv. Our preliminary data thus clearly demonstrate that the MGIT 960
method  can be considered as a promising alternative to BACTEC 460 method.
drug  resistant TB in HIV infected individuals is a leading cause
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Tuberculosis (TB) is a global pandemic and a re-emerging bac-
terial  infectious disease caused by obligate human pathogen
Mycobacterium tuberculosis. It affects one third of the human
population.1 There is an estimated 2.5 billion people infected
with  TB worldwide with 8.7 million (range 8.3–9.0 million)
new  cases, and an annual mortality of approximately 1.0
million  (range 0.84–1.1 million) people, and an additional
mortality of 0.43 million (range 0.40–0.46 million) among
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1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licençahuman immunodeﬁciency virus (HIV)-infected people.2 TB
kills  one individual in every 18 s and infects an individual
every second.3 Despite the availability of effective drugs to
treat  TB patients, we  have failed to stop the menace of this
deadly  disease, which has worsened due to emergence of both
multidrug-resistant tuberculosis (MDR-TB) and extensively
drug-resistant (XDR-TB).4–6 The increase in the incidence ofof  death, and is further worsening the TB situation worldwide.
The  major phenomenon in the development of TB
in  humans is considered to be an interaction between
 de CC BY-NC-ND
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acrophages and the mycobacteria. Various standardized
ethods are commonly used to study the susceptibility to
rugs  of intracellular mycobacteria such as plating, micro
late  alamar blue assay and BACTEC 460.7–9
Both plating (conventional) method and BACTEC 460
Becton, Dickinson, USA) are considered as gold-standard
or measuring the growth of intracellular mycobacteria in
acrophages.7–11 Plating method requires longer period of
ncubation  (almost three weeks) and the results are com-
romised by cross contamination. However BACTEC 460
ystem  has a shorter period of incubation, is highly sen-
itive  and reproducible, but it also has certain limitations.
irstly, it involves the use of radioisotopes and requires spe-
ial  attention during disposal.12 Secondly, it is labor intensive,
emi-automated, needs considerable hands on time.12 More-
ver,  BACTEC 460 has been discontinued by manufacturer due
o radioactivity related safety issues.
Therefore, there is an urgent need to develop/standardize
ew methods, which are free of such limitations. Several eval-
ations  concerning antimicrobial susceptibility testing using
GIT  (mycobacterial growth indicator tube; Becton Dickinson,
SA)  medium have already been reported.13–16 Its perfor-
ance has been found to be equivalent to radiometric BACTEC
60,  plating and other methods.16 In this study, we have tried
o  standardize the method for studying the effect of isoni-
zid  (INH), rifampin (RIF), ethambutol (EMB) and streptomycin
STP)  against intramacrophage M. tuberculosis, in vitro using
GIT  960, which is a fully automated, non-radioactive (use
 ﬂuorescence quenching based oxygen sensor), and non-
nvasive  system. In this MGIT 960 system, tubes are monitored
utomatically within in-built incubation system. Every tube is
onitored hourly and speciﬁc algorithms that determine the
ositivity  of tubes are drawn automatically.13–16
aterials  and  methods
NH, RIF, EMB  and STP were purchased from Becton Dickin-
on,  USA. These drugs were used to test the susceptibilities
f the mycobacteria using BACTEC 460 and MGIT 960 system.
he  solutions of these standard drugs were prepared in sterile
ater  as per manufacturers’ instructions.
M. tuberculosis H37Rv was  obtained from Tuberculosis
esearch Centre (TRC), Chennai, India. The organisms were
rown  in complete 7H9 broth (Difco, USA) supplemented
ith 1% glycerol, 0.05% Tween-80 (Sigma–Aldrich, USA) and
0%  Middlebrook OADC enrichment (Difco). Log phase cul-
ures  of mycobacteria were centrifuged and washed thrice
ith  saline. After washing, pellets were  re-suspended in
aline  and allowed to stand at room temperature for 10 min.
he  mycobacterial suspension was  adjusted to 1 McFarland
tandard (3 × 108 cells/mL) with DMEM containing 1% fetal calf
erum  for inoculation. The purity of culture was  checked by
iehl–Neelsen  staining (Hi-Media, India).
Swiss mice (male/female; 18–20 g) were obtained from the
entral  animal facility of the institute and maintained in 12-
 light/dark cycle at 37 ◦C, with food and water provided ad
ibitum.  All studies were  carried out in accordance with the
uidelines  for care and use of animals in scientiﬁc research,4;1 8(3):336–340  337
Indian  National Science Academy, New Delhi as adapted and
promulgated  by the institutional animal ethics committee.
Thioglycolate elicited mouse peritoneal macrophages
(PMs) exudate cells were isolated as described earlier.17 Brieﬂy,
the  cells were washed and ﬁnally suspended in antibiotic-
free  DMEM (PAA lab, Austria) containing 2 mM l-glutamine
(PAA lab), 0.01 M HEPES (HiMedia, India) and 1 × 10−4 M 2-
mercaptoethanol, supplemented with 10% FBS (PAA Lab;
CDMEM).  The cell pellets were  seeded in 24-well sterile tis-
sue  culture plates with 1 × 106 cells/well in a total volume of
2  mL  per well. The cells were incubated overnight at 37 ◦C in 5%
CO2 incubator for adherence, and the non-adherent cells were
washed-off  with warm Hank’s balanced salt solution (HBSS).
Purity  of PMs  was  checked as per morphologic, phagocytic
and  non-speciﬁc esterase staining criteria, and viability was
judged  by trypan blue dye exclusion method.17
Adherent layer of PMs was  infected with M.  tuberculosis
H37Rv suspension containing 107 bacteria per well (multi-
plicity  of infection 10:1) and the phagocytosis was  allowed
for  4 h at 37 ◦C in 5% CO2 atmosphere. All the extracellular
mycobacteria were  washed by three changes of warm HBSS.
The  contents of the wells were replaced with fresh DMEM with
or  without drugs and incubated in (37◦ C, 5% CO2) incubator.
Supernatant was  removed after speciﬁc periods (four days and
seven  days) of incubation, washed three times with HBSS and
PMs  were lysed by addition of 0.4 mL  of 0.25% sodium dod-
edcyl  sulphate and 1.1 mL  of Middle Brook 7H9 media. After
10  min  of incubation, 0.5 mL  of 20% bovine serum albumin
was  added and further incubated for 10 min. The cell sus-
pension  was  vortexed, sonicated and drawn up and down
through  a needle so as to get homogeneous single cell sus-
pension.
Antibiotic  susceptibility was  performed by radiometric
BACTEC 460 TB system as per standard protocol.15 Different
dilutions of macrophage lysates (as prepared above) were inoc-
ulated in BACTEC 12 B vials in triplicate and incubated at 37 ◦C
in  5% CO2 atmosphere. Results were read every 24 h in BACTEC
460  TB system. Appropriate positive and negative controls
were  also taken. Growth index (GI) determination was  done
daily  under aerobic mode in BACTEC 460 TB system until 1:100
controls  reading reached the value of 30.
The antibiotic susceptibility was  also performed with MGIT
960  in accordance with the standard procedure.18 MGIT 960
system  uses oxygen quenching ﬂuorescent sensor in con-
junction  with software algorithms to determine the “positive”
tubes.  MGIT 960 system monitors the vials for oxygen utiliza-
tion,  which result in an increase in ﬂuorescence as an indicator
of  growth. Different dilutions of macrophage lysates (as pre-
pared  above) were inoculated in MGIT 960 tubes in triplicate.
Bacterial growth is determined in terms of growth units (GU).
Appropriate  positive and negative controls were  included. GU
was monitored in MGIT 960 system until 1:100 control reading
reached  the threshold value.
Both the methods were employed to determine MICs of
standard  drugs. In BACTEC 460, the MIC is deﬁned as the low-
est  concentration of drug at which the increase in GI was equal
19,20to  or less than that of control (1:100). In MGIT 960, the MIC
is  deﬁned as the lowest dilution that gives negative results by
automated reading in drug-containing tubes when the 1:100
control  vials turned positive.18
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Fig. 1 – Typical radiometric data illustrating the MIC  level of Isoniazid (INH), Rifampin (RIF), Ehambutol (EMB) and
Streptomycin (STP); at 4 day (a) and 7 day (b) interval against the drug susceptible M.  tuberculosis strain. PMs (2 × 106) were
infected in culture at a bacterium to macrophage ratio (10:1). Infected PMs  without drug treatment were used as control
(1:100). Error bars represent the standard deviation from mean. Values are mean ± SD of three separate experiments, run in
triplicate. Statistical analysis was  performed by ANOVA and Tukey’s multiple comparison test. The growth was  monitored
m.radiometrically in 7H12 broth with the BACTEC 460 TB syste
All results were  analyzed using Sigma plot Statistical Soft-
ware  11.0. The values were  expressed as mean ± SD of three
separate  experiments, run in triplicate. Multiple groups were
analyzed  by one-way ANOVA followed by Turkey’s multiple
comparison tests. p < 0.05 was  considered as statistically sig-
niﬁcant.
Results
In the present study, MICs of RIF, INH, EMB,  and STP were deter-
mined  against intramacrophage M. tuberculosis H37Rv, in vitro.
MICs of INH, RIF, EMB,  and STP against intracellular M.  tuber-
culosis  H37Rv were  found to be 0.2, 0.8, 8.0, and 5.0 g/mL
respectively, by both BACTEC 460 and MGIT 960 methods. Fig. 1
show that INH was  also effective (p < 0.001) in killing the M.
tuberculosis  H37Rv-infected PMs  at 0.05, 0.1 and 0.2 g/mL con-
centrations  using BACTEC 460 at 4th day and 7th day. Similarly,
Fig.  1 also summarizes the effect of RIF, EMB, STP against M.
tuberculosis  H37Rv-infected PMs. RIF was  found to be effective
at  0.2, 0.4 and 0.8 g/mL concentrations using BACTEC 460 at
4th  day and 7th day (Fig. 1). EMB  was  found to be effective at
2.0,  4.0 and 8.0 g/mL concentrations using BACTEC 460 at 4th
day  and 7th day (Fig. 1). In the same way,  STP was  effective at
1.25,  2.50, 5.0 g/mL against intracellular M. tuberculosis (Fig. 1).
The  results were  found to be highly statistically signiﬁcant
(p  < 0.001). In the same way,  various concentrations of INH, RIF,
EMB and STP showed almost similar effect in killing the intra-
cellular  M.  tuberculosis H37Rv using MGIT 960 at 4th day and7th day. These results were also found to be highly statistically
signiﬁcant (p < 0.001) at all the three different concentrations.
Various growth stages of mycobacteria using epicenter soft-
ware  are shown in Fig. 2.
Discussion
Plating method is a laborious procedure and requires long
period  of incubation. Since 1994, BACTEC 460 has been widely
employed  for determining the anti-tubercular activity of var-
ious  drugs against intracellular M. tuberculosis H37Rv, and it
gives results within 5–6 days. But due to increasing concerns
about  radioactivity and its disposal, it has been discontin-
ued/phased out by the manufacturer. Therefore, there is an
urgent  need to standardize a method to overcome these
shortcomings. Although, there is no impendent to M. tuber-
culosis  H37Rv susceptibility testing with non-automated liquid
media,  only automated system like MGIT 960 has the potential
to  replace the semi-automated BACTEC 460 TB system. Among
all  the automated systems, MGIT 960 has shown good sensi-
tivity  and reliability for screening the anti-tubercular activity
of  drugs, in vitro. Here, we have tested the utility, reliability
and  reproducibility of MGIT 960 to determine the intracel-
lular  activity of four anti-TB drugs RIF, INH, EMB, and STP
against  M. tuberculosis H37Rv, in vitro. We have evaluated the
BACTEC  460 TB against MGIT 960, and a good correlation was
observed  between the two methods for all the drugs tested in
this model. Time needed for test completion was  found to be
b r a z j i n f e c t d i s . 2 0 1 4;1 8(3):336–340  339
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Fig. 2 – MGIT growth and detection plot. Red line indicates growth units of inoculated culture and green line indicates
threshold value (minimum value of growth units at which our culture sample become positive). (A) No growth; (B) increase
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lmost similar for these methods. The MGIT 960 system has
everal  advantages over the widely used BACTEC 460 system. It
s less labor intensive and no radioactive material is involved;
oreover, it is safer for laboratory personnel. Although MGIT
60  has been used for anti-tubercular testing, this is the ﬁrst
eport  of use of MGIT 960 for anti-tubercular susceptibility
esting against intracellular M. tuberculosis H37Rv. MGIT 960
s  easy, precise and less hazardous for determination of MICs
n  intracellular model. Thus MGIT 960 system has a good
otential and it appears to be a valid alternative to BACTEC
60  radiometric system in the determination of antibacte-
ial  activity of various drugs against intracellular TB bacilli
n  macrophage model. Further studies may  be performed
sing different M.  tuberculosis isolates against ﬁrst-line and
econd-line  anti-TB drugs to evaluate MGIT 960 utility in deter-
ination  of intracellular MICs. MGIT 960 system appears to be
 good alternative/addition to existing methods for carrying
ut  susceptibility testing against intracellular M.  tuberculosis.
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